Kotak Bluechip Fund has been an alpha generator in the long run. Looking at its five-year rolling returns, the fund has outperformed its benchmark and fellow large-cap fund rivals by 1 to 1.15 per cent. While the fund did suffer a blip last year, it is steadily clawing its way back. It started showing signs of recovery in the first half of this year. In the last six months, too, it has beaten the index. Though the fund lags behind the median category performance in this period, the gap is merely 20 bps. Performance breakdown Chemical holdings such as Solar Industries India and Coromandel International have uplifted the fund's performance. , Persistent Systems and Gland Pharma are the other notable contributors. The fund has also benefited from its bets
Buy, hold, or switch. Get the call.
How's my portfolio doing? What do I need to fix? Where should I invest next? Fund Advisor answers each one. The Advisor Note every Saturday. A live session with Dhirendra Kumar every second Saturday.
No commissions. No conflicts. Since 1991.
See Plans
Already a subscriber ?Log In
New episodes every Friday 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
